Back to News
Market Impact: 0.6

Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom

CMEFITBCMACFG
Monetary PolicyInterest Rates & YieldsBanking & LiquidityCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst Estimates
Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom

Anticipation of Federal Reserve interest rate cuts, with a 68% probability by September according to CME FedWatch, is positioning bank stocks for potential gains. A steepening yield curve, driven by lower short-term rates and stable long-term rates post-cut, is expected to expand banks' Net Interest Margins (NIMs). Fifth Third Bancorp (FITB), Comerica (CMA), and Citizens Financial Group (CFG) are specifically identified as beneficiaries, leveraging strong capital positions, diversified loan portfolios, and strategic balance sheet adjustments to capitalize on this environment for enhanced profitability and shareholder returns.

Analysis

Market consensus, as indicated by the CME FedWatch tool, is pricing in a 68% probability of a Federal Reserve rate cut by September, a catalyst that is expected to be particularly bullish for the banking sector. The primary mechanism for this positive outlook is the anticipated steepening of the yield curve, where lower short-term borrowing costs combined with stable or rising long-term rates would expand banks' Net Interest Margins (NIMs). The analysis highlights three regional banks poised to benefit. Fifth Third Bancorp (FITB) is already demonstrating strength with five consecutive quarters of NIM expansion and 3% year-over-year loan growth, supported by a robust 10.5% CET1 ratio and a 100 million share buyback program. Comerica (CMA), as a highly asset-sensitive bank, has seen recent earnings pressure but is positioned for a significant rebound; despite management projecting a 1-2% decline in full-year 2025 average loans, EPS is forecast to grow over 9% this year, backed by a strong 12.5% CET1 ratio. Finally, Citizens Financial Group (CFG) has proactively repositioned its balance sheet into higher-yielding commercial loans and presents a compelling valuation case, with analysts projecting 27% EPS growth over the next 12 months against a forward P/E ratio of approximately 10x, further supported by a $1.5 billion share repurchase authorization and a 10.6% CET1 ratio.